Sex hormone-binding globulin gene expression in the liver: drugs and the metabolic syndrome. Pugeat M, Nader N, Hogeveen K, Raverot G, Déchaud H, Grenot C.Mol Cell Endocrinol. 2009 Sep 25.

[Endoscopy versus microsurgery: Results in a consecutive series of nonfunctioning pituitary adenomas.] Kassis S, De Battista JC, Raverot G, Jacob M, Simon E, Rabilloud M, Froehlich P, Trouillas J, Borson-Chazot F, Perrin G, Jouanneau E. Neurochirurgie. 2009 Sep 3. [Epub ahead of print] French.

Sex hormone-binding globulin predicts the incidence of hyperglycemia in women: interactions with adiponectin levels. Bonnet F, Balkau B, Malécot JM, Picard P, Lange C, Fumeron F, Aubert R, Raverot V, Déchaud H, Tichet J, Lecomte P, Pugeat M; DESIR Study Group. Eur J Endocrinol. 2009 Jul;161(1):81-5. Epub 2009 May 8

Prevalence and function of anti-lipoprotein lipase auto-antibodies in type V hyperchylomicronemia. Moret M, Pruneta-Deloche V, Sassolas A, Marcais C, Moulin P. Atherosclerosis. 2009 Jul 28. [Epub ahead of print] 

Noninvasive assessment of the prevalence and characteristics of coronary atherosclerotic plaques by multidetector computed tomography in asymptomatic type 2 diabetic patients at high risk of significant coronary artery disease: A preliminary study. Loffroy R, Bernard S, Sérusclat A, Boussel L, Bonnefoy E, D'Athis P, Moulin P, Revel D, Douek P. Arch Cardiovasc Dis. 2009 Aug-Sep;102(8-9):607-15. Epub 2009 Jun 25.

A controlled study of consumption of beta-glucan-enriched soups for 2 months by type 2 diabetic free-living subjects. Cugnet-Anceau C, Nazare JA, Biorklund M, Le Coquil E, Sassolas A, Sothier M, Holm J, Landin-Olsson M, Onning G, Laville M, Moulin P. Br J Nutr. 2009 Sep 28:1-7. [Epub ahead of print]

Noninvasive measurement of carotid extra-media thickness: associations with cardiovascular risk factors and intima-media thickness.Skilton MR, Sérusclat A, Sethu AH, Brun S, Bernard S, Balkau B, Moulin P, Bonnet F. JACC Cardiovasc Imaging. 2009 Feb;2(2):176-82.

The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. Burnichon N, Rohmer V, Amar L, Herman P, Leboulleux S, Darrouzet V, Niccoli P, Gaillard D, Chabrier G, Chabolle F, Coupier I, Thieblot P, Lecomte P, Bertherat J, Wion-Barbot N, Murat A, Venisse A, Plouin PF, Jeunemaitre X, Gimenez-Roqueplo AP; PGL.NET network. J Clin Endocrinol Metab. 2009 Aug;94(8):2817-27. Epub 2009 May 19.

Modulation of phenotypic expression of APOA5 Q97X and L242P mutations. CharrièreS, Cugnet C, Guitard M, Bernard S, Groisne L, Charcosset M,Pruneta-Deloche V, Merlin M, Billon S, Delay M, Sassolas A, Moulin P,Marçais C. Atherosclerosis. 2009 Apr 24. [Epub ahead of print]

Predicting visual outcome after treatment of pituitary adenomas with optical coherence tomography. 

Jacob M, Raverot G, Jouanneau E, Borson-Chazot F, Perrin G, Rabilloud M, Tilikete C, Bernard M, Vighetto A.Am J Ophthalmol. 2009 Jan;147(1):64-70.e2. Epub 2008 Sep 6.PMID: 18774545 [PubMed - indexed for MEDLINE] 2009-AmOpht-OCT.pdf2009-AmOpht-OCT.pdf  

From paediatric to adult endocrinology care: the challenge of the transition period. Pugeat M, Nicolino M. Pediatr Endocrinol Rev. 2009 Jun;6 Suppl 4:519-22. Review.

Development of a radioimmunoassay for the measurement of Bisphenol A in biological samples. Kaddar N, Bendridi N, Harthé C, de Ravel MR, Bienvenu AL, Cuilleron CY, Mappus E, Pugeat M, Déchaud H. Anal Chim Acta. 2009 Jul 10;645(1-2):1-4. Epub 2009 May 3

Molecular characteristics of papillary thyroid carcinomas without BRAF mutation or RET/PTC rearrangement. Relationship with clinicopathological features. 

Durand S, Ferraro-Peyret C, Joufre M, Chave A, Borson-Chazot F, Selmi-Ruby S, Rousset B.

Endocr Relat Cancer. 2009 Feb 10. [Epub ahead of print] PMID: 19208736 [PubMed - as supplied by publisher] 

Thyroid cancer: is the incidence rise abating? Sassolas G, Hafdi-Nejjari Z, Remontet L, Bossard N, Belot A, Berger-Dutrieux N, Decaussin-Petrucci M, Bournaud C, Peix JL, Orgiazzi J, Borson-Chazot F.Eur J Endocrinol. 2009 Jan;160(1):71-9. Epub 2008 Oct 24.PMID: 18952764 [PubMed - indexed for MEDLINE]

Guidelines for the management of differentiated thyroid carcinomas of vesicular origin. Borson-Chazot F, Bardet S, Bournaud C, Conte-Devolx B, Corone C, D'Herbomez M, Henry JF, Leenhardt L, Peix JL, Schlumberger M, Wemeau JL; Expert Group for French Recommendations for the Management of Differentiated Thyroid Carcinomas of Vesicular Origin, Baudin E, Berger N, Bernard MH, Calzada-Nocaudie M, Caron P, Catargi B, Chabrier G, Charrie A, Franc B, Hartl D, Helal B, Kerlan V, Kraimps JL, Leboulleux S, Le Clech G, Menegaux F, Orgiazzi J, Perié S, Raingeard I, Rodien P, Rohmer V, Sadoul JL, Schwartz C, Tenenbaum F, Toubert ME, Tramalloni J, Travagli JP, Vaudrey C. Ann Endocrinol (Paris). 2008 Dec;69(6):472-86. Review. No abstract available

Thirteen-month registration of patients with gastroenteropancreatic endocrine tumours in France.Lombard-Bohas C, Mitry E, O'Toole D, Louvet C, Pillon D, Cadiot G, Borson-Chazot F, Aparicio T, Ducreux M, Lecomte T, Etienne PL, Cacheux W, Legoux JL, Seitz JF, Ruszniewski P, Chayvialle JA, Rougier P; FFCD-ANGH-GERCOR. Neuroendocrinology. 2009;89(2):217-22. Epub 2008 Aug 22

Parity and Carotid Atherosclerosis in Men and Women. Insights Into the Roles of Childbearing and Child-Rearing.
Skilton MR, Sérusclat A, Begg LM, Moulin P, Bonnet F.Stroke. 2009 Feb 10. [Epub ahead of print] PMID: 19211493 [PubMed - as supplied by publisher]

Efficacy of benfluorex in combination with sulfonylurea in type 2 diabetic patients: An 18 to 34-week, open-label, extension period.Moulin P, André M, Alawi H, Dos Santos LC, Khalid AK, Koev D, Moore R, Serban V, Picandet B, Francillard M. Diabetes Metab. 2009 Jan 14. [Epub ahead of print] PMID: 19150252 [PubMed - as supplied by publisher]

Modulation of the postprandial phase by beta-glucan in overweight subjects: effects on glucose and insulin kinetics. Nazare JA, Normand S, Oste Triantafyllou A, Brac de la Perrière A, Desage M, Laville M. Mol Nutr Food Res. 2009 Mar;53(3):361-9.